Home › Kidney Cancer (Renal Cell Carcinoma) › Rhode Island › Providence
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Providence, RI
4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
RecruitingPhase 1/2
- Rhode Island Hospital, East Providence · 2 mi away
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
RecruitingPhase 1/2
- Lifespan Cancer Institute, Providence
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RecruitingPhase 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- Brown University Health Cancer Institute, Providence
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Dallas, TX23 studies
- Nashville, TN23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Cleveland, OH14 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)12 studies
- Crohn's Disease12 studies
- Breast Cancer11 studies
- Ulcerative Colitis11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Overweight9 studies
- Alcohol Use Disorder (AUD)8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.